MedPath

Augmenting internet-delivered cognitive behaviour therapy (iCBT) with daily SMS prompts for adults with chronic pain: an open trial to examine efficacy and acceptability.

Not Applicable
Recruiting
Conditions
Chronic Pain
Anxiety
Depression
Anaesthesiology - Pain management
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12613000926730
Lead Sponsor
ational Health and Medical Research Council (NHMRC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Has experienced Chronic Pain (i.e. Pain > 6 months)
- Internet access + Printer access
- Australian resident
- Has had their pain assessed by their GP or medical specialist.

Exclusion Criteria

- Active psychosis
- Pain not assessed by GP
- Severe depression, suicidal intent or plan (PHQ-9 total score > 22)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Roland Morris Disability Questionnaire (RMDQ), which measures disability associated with pain.[Application, pre-treatment, post-treatment and 3, 12 and 24 month follow-up];Patient Health Questionnaire 9-Item (PHQ9), which is a measure of depression.[Application, pre-treatment, post-treatment and 3, 12 and 24 month follow-up];Generalized Anxiety Disorder 7-Item (GAD7), which is a measure of anxiety.[Application, pre-treatment, post-treatment and 3, 12 and 24 month follow-up]
Secondary Outcome Measures
NameTimeMethod
Wisconsin Brief Pain Questionnaire (WBPQ), which is a general measure of the nature of participants pain including location, severity and duration.[Application, pre-treatment, post-treatment and 3, 12 and 24 month follow-up];Pain Things You Do Questionnaire (PTYDQ), which is a measure of helpful cognitive and behavioural skill use.[Pre-treatment, post-treatment and 3, 12 and 24 month follow-up];Employment and health service use will be measured by the Employment and Health Service Use Questionnaire[Pre-treatment and 3, 12 and 24 month follow-up.]
© Copyright 2025. All Rights Reserved by MedPath